Polymorphisms Xbal (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2

被引:22
作者
Starcevic, Jovana Nikolajevic [1 ]
Letonja, Marija Santl [2 ]
Praznikar, Zala Jenko [3 ]
Makuc, Jana [4 ]
Vujkovac, Andreja Cokan [4 ]
Petrovic, Daniel [1 ]
机构
[1] Univ Ljubljana, Fac Med, Inst Histol & Embryol, Ljubljana 61000, Slovenia
[2] Gen Hosp Rakican, Murska Sobota, Slovenia
[3] Univ Primorska, Fac Hlth Sci, Dept Nat & Med Sci, Koper, Slovenia
[4] Gen Hosp Slovenj Gradec, Slovenj Gradec, Slovenia
关键词
Diabetes mellitus; carotid atherosclerosis; apolipoprotein B; polymorphism; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; DNA POLYMORPHISMS; LIPID-LEVELS; DISEASE; ATHEROSCLEROSIS; METAANALYSIS; DYSLIPIDEMIA;
D O I
10.1024/0301-1526/a000346
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Apolipoprotein B is a key structural component of all the atherogenic lipoproteins (LDL, VLDL and IDL). Genetic variations of the ApoB gene may affect plasma ApoB and lipid levels, thus influencing atherogenesis. The present study was designed to investigate the association of polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene with plasma ApoB level, lipid levels and the different ultrasound phenotypes of carotid atherosclerosis in patients with diabetes mellitus type 2. Patients and methods: 595 patients with diabetes (399 on statin therapy and 196 without) and 200 healthy controls were enrolled in the study. The carotid intima-media thickness (CIMT) and plaque characteristics (presence and structure) were assessed ultrasonographically. Biochemical analyses were performed using standard biochemical methods. Both XbaI (rs693) and EcoRI (rs1042031) genotypes were determined by real-time PCR. Results: Genotype distributions and allele frequencies of the XbaI and EcoRI polymorphisms were not statistically significantly different between diabetic patients and controls. No statistically significant difference in lipid parameters, ApoA1, ApoB, hs-CRP and fibrinogen as well as CIMT was observed in diabetic patients regarding XbaI and EcoRI polymorphisms, even after adjustment for statin treatment. The risk of having plaques on carotid arteries was higher in homozygous carriers of the mutant X+ allele (OR = 1.74, p = 0.03) and lower in diabetics carrying mutant E- alleles (OR = 0.48, p = 0.02). Neither XbaI nor EcoRI polymorphism was associated with CIMT or presence of unstable plaques in diabetic patients. Plasma ApoB level was not independently associated with any of the ultrasonographic parameters of carotid atherosclerosis. Conclusions: Both XbaI and EcoRI polymorphisms were associated with presence of plaques on carotid arteries but not with CIMT or presence of unstable plaques. Plasma ApoB level was not independently associated with ultrasonographic phenotypes of carotid atherosclerosis in patients with diabetes mellitus.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 31 条
[1]   Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels [J].
Ballantyne, CM ;
Andrews, TC ;
Hsia, JA ;
Kramer, JH ;
Shear, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :265-269
[2]   Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].
Barter, PJ ;
Ballantyne, CM ;
Carmena, R ;
Cabezas, MC ;
Chapman, MJ ;
Couture, P ;
De Graaf, J ;
Durrington, PN ;
Faergeman, O ;
Frohlich, J ;
Furberg, CD ;
Gagne, C ;
Haffner, SM ;
Humphries, SE ;
Jungner, I ;
Krauss, RM ;
Kwiterovich, P ;
Marcovina, S ;
Packard, CJ ;
Pearson, TA ;
Reddy, KS ;
Rosenson, R ;
Sarrafzadegan, N ;
Sniderman, AD ;
Stalenhoef, AF ;
Stein, E ;
Talmud, PJ ;
Tonkin, AM ;
Walldius, G ;
Williams, KMS .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258
[3]  
Beekman M, 2002, TWIN RES, V5, P87, DOI 10.1375/twin.5.2.87
[4]   Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population [J].
Benn, Marianne ;
Stene, Maria C. A. ;
Nordestgaard, Borge G. ;
Jensen, Gorm B. ;
Steffensen, Rolf ;
Tybjaerg-Hansen, Anne .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) :1038-1045
[5]   Relation between XbA1 apolipoprotein B gene polymorphism and cardiovascular risk in a type 2 diabetic cohort [J].
Bernard, S ;
Charrière, S ;
Charcosset, M ;
Berthezène, F ;
Moulin, P ;
Sassolas, A .
ATHEROSCLEROSIS, 2004, 175 (01) :177-181
[6]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[7]   Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis [J].
Boekholdt, SM ;
Peters, RJG ;
Fountoulaki, K ;
Kastelein, JJP ;
Sijbrands, EJG .
HUMAN GENETICS, 2003, 113 (05) :417-425
[8]  
BOHN M, 1993, CLIN GENET, V44, P241
[9]   APO B gene polymorphisms and coronary artery disease: a meta-analysis [J].
Chiodini, BD ;
Barlera, S ;
Franzosi, MG ;
Beceiro, VL ;
Introna, M ;
Tognoni, G .
ATHEROSCLEROSIS, 2003, 167 (02) :355-366
[10]   ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS [J].
DEGRAAF, J ;
HAKLEMMERS, HLM ;
HECTORS, MPC ;
DEMACKER, PNM ;
HENDRIKS, JCM ;
STALENHOEF, AFH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :298-306